Huvepharma Sea (Pune) Private Limited - Company Profile

It is a pharma foreign private limited company based in Pune, Maharashtra, India, established in 2009.

2009 Pune, Maharashtra, India Active

Last Updated: December 29, 2025

About Huvepharma Sea (Pune) Private Limited

Huvepharma Sea (Pune) Private Limited, a active foreign private limited company, was established on 30 November 2009 in Pune, Maharashtra, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U15122PN2009FTC135083. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.30 Cr and a paid-up capital of ₹1.30 Cr.

It upholds a compliant status. Employing 61 professional, Its leadership includes Viktor Nikolaev Prodanov (Director), Kiril Petrov Domuschiev (Director), Om Prakash Balmiki Singh (Managing Director). Past directors included Viktor Nikolaev Prodanov, Om Prakash Balmiki Singh, Tsetsko Stanev Tsvetkov. It holds ₹21.05 Cr open charges and ₹12.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 42, Haridwar Bunglow, S.N. 213, Road No. 2 A/B, Kalyani Nagar,, Pune, Maharashtra, 411006.

Company Details

CIN/LLPIN
U15122PN2009FTC135083
Registration Number
135083
Incorporation Date
30 November 2009
Authorized Capital
₹1.30 Cr
Paid-Up Capital
₹1.30 Cr
ROC Code
Roc Pune
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.30 Cr as on 29-12-2025
Paid Up Capital ₹ 1.30 Cr as on 29-12-2025
Company Age 16 Year, 2 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 21.05 Cr as on 29-12-2025
Satisfied Charges ₹ 12.00 Cr as on 29-12-2025
Revenue Growth **** 3.62% (FY 2023)
Profit Growth **** -5.03% (FY 2023)
Ebitda **** -3.48% (FY 2023)
Net Worth 30.55% (FY 2023)
Total Assets **** 12.19% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Huvepharma Sea (Pune) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Huvepharma Sea (Pune) Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Viktor Nikolaev Prodanov	Director	11 Nov 2011	Current
Kiril Petrov Domuschiev	Director	30 Nov 2009	Current
Om Prakash Balmiki Singh	Managing Director	30 Nov 2009	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	29 Sep 2012	Past
Pramod Abcsdd	Director	30 Nov 2009	Past
Pramod Abcsdd	Director	10 Sep 2011	Past
Pramod Abcsdd	Director	09 Mar 2010	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Huvepharma Sea (Pune).

Huvepharma Sea (Pune) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.62% increase. The company also saw a slight decrease in profitability, with a 5.03% decrease in profit. The company's net worth Soared by an impressive increase of 30.55%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

3.62%

*******

Revenue from Operations

*******

4.53%

*******

Total Assets

*******

12.19%

*******

Profit or Loss

*******

-5.03%

*******

Net Worth

*******

30.55%

*******

EBITDA

*******

-3.48%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Huvepharma Sea (Pune)?

In 2023, Huvepharma Sea (Pune) had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹210,487,340.00

Satisfied Charges

₹120,000,000.00

Charges Breakdown by Lending Institutions

Citi Bank N.A. : 20.00 Cr
Axis Bank Limited : 1.05 Cr

Latest Charge Details

Date	Lender	Amount	Status
31 Aug 2021	Axis Bank Limited	₹1.05 Cr	Open
26 Nov 2014	Citi Bank N.A.	₹20.00 Cr	Open
28 May 2018	Citi Bank N.A.	₹5.00 Cr	Satisfied
20 Sep 2017	Citi Bank N.A.	₹5.00 Cr	Satisfied
17 Jan 2011	Bank Of India	₹2.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Huvepharma Sea (Pune)?

Huvepharma Sea (Pune) has a workforce of 61 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Huvepharma Sea (Pune), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Huvepharma Sea (Pune)'s trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Huvepharma Sea (Pune)

Recent Activity within the Organization

Annual General Meeting

Progress on Huvepharma Sea (Pune) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
30 Sep 2024
Charges

A charge registered on 28 May 2018 via Charge ID 100224517 with Citi Bank N.A. was fully satisfied on 16 Jul 2024. was recorded as a recent event.
16 Jul 2024
Charges

Progress on A charge registered on 20 Sep 2017 via Charge ID 100140768 with Citi Bank N.A. was fully satisfied on 16 Jul 2024. was documented.
16 Jul 2024
Balance Sheet

Progress on Huvepharma Sea (Pune) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
31 Mar 2024
Charges

The activity A charge with Axis Bank Limited amounted to Rs. 1.05 Cr with Charge ID 100480653 was registered on 31 Aug 2021. was completed.
31 Aug 2021
Charges

A charge with Citi Bank N.A. of Rs. 20.00 Cr registered on 26 Nov 2014 with Charge ID 10535343 was modified on 15 Jul 2019. was recorded as a recent event.
15 Jul 2019

Explore recent activity and updates - View Recent Activity